Melissa Cushing, MD
Clinical Pathology/Laboratory Medicine · New York, NYNPI 1316024839
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $85,507 of the $139,186 with a category attached, or 61.4%. 9 manufacturers reported payments, led by Cerus Corporation at 27.8% of the total. 2025 is the largest year on record at $52,262, 7.7 times the $6,790 reported in 2019. Among clinical pathology/laboratory medicine clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 106 payments — averaging $1313.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cerus Corporation$39K
- CSL Behring$28K
- Octapharma USA, Inc.$23K
- Instrumentation Laboratory Company$18K
- Haemonetics Corporation$16K
- Grifols Shared Services North America, Inc.$16K
- plus $314 from 3 others
Across 31 payments — averaging $28,347 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Cerus Corporation$861K
- Octapharma USA, Inc.$17K
What the payments were for
- Consulting fees$85,50761%
- Speaking & faculty fees$25,82019%
- Travel & lodging$23,74317%
- Food & beverage$3,8243%
- Education$1790%
- Gifts$1120%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cerus Corporation | 29 | $38,670 |
| CSL Behring | 18 | $27,550 |
| Octapharma USA, Inc. | 23 | $22,697 |
| Instrumentation Laboratory Company | 16 | $18,106 |
| Haemonetics Corporation | 14 | $16,264 |
| Grifols Shared Services North America, Inc. | 3 | $15,584 |
| Baxter Healthcare | 1 | $124 |
| Hemosonics LLC | 1 | $103 |
| Werfen USA LLC | 1 | $87 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTERCEPT BLOOD SYSTEM FOR CRYOPRECIPITATION$25,019
- RiaSTAP$18,833
- OCTAPLAS$15,609
- INTERCEPT BLOOD SYSTEM FOR PLATELETS$11,452
- FIBRYGA$6,500
- TEG6s HEMOSTASIS SYSTEM$2,800
- DEVICE-TRANSFUSION$2,000
- No Related Product$124
- QUNATRA QPLUS SYSTEM$103
- Quantra QPlus System$103
How this compares
$139,186 in reported general payments places this provider in the 95th percentile of 37 clinical pathology/laboratory medicine providers in New York.
See all clinical pathology/laboratory medicine providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other clinical pathology/laboratory medicine in New York
- Anjali SaqiNew York$182K
- Ahmet DoganNew York$25K
- Matthew GreenblattNew York$19K
- Alexander KratzNew York$3K
- Daniel GreenNew York$3K
- Ila SinghNew York$2K
- Tobias CohenNew York$266
- Anthony CardilloNew York$135
- Elena MaryamchikNew York$97
- Amanda BlouinNew York$45
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.